Delivery Order SPE2DB22D3301-SPE2DB24FZ2TC

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $132K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency awarded a $9,124.32 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,562,696,707 units of Eliquis 5 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
The U.S. Defense Logistics Agency (DLA) awarded a $1,187.55 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division to supply 4,564,361,392 units of the prescription medication Eliquis 2.5 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $16,544.69 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets and has an ultimate completion date of January 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division to provide 4,565,911,241 Eliquis 5 mg tablets. The fixed-price contract, valued at $3,025.68, has a period of performance through September 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the supply of a wide range of pharmaceutical and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $6,418.76 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities, including prescription drugs, to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $17,821.43 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,743.83 contract is for the supply of 60 tablets of the prescription drug Eliquis 5 mg, with a completion date of March 7, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,119.95 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of Eliquis 5 mg tablets and has a performance period through March 13, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which was not set aside under any socioeconomic programs. Additionally, AmerisourceBergen Drug Corp holds an Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,008,777 tablets of Eliquis 5 mg. The $3,061.31 contract has a performance period through March 20, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp also holds a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. This $9,313.70 contract is for the delivery of 4,563,926,216 units of the medication Eliquis 5 mg tablets. The contract has an ultimate completion date of March 12, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an indefinite delivery contract with...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2TC
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $132,002.22 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. for the supply of 4,565,427,049 units of Eliquis 5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion on August 13, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to deliver essential medications and medical supplies to various federal agencies and healthcare providers, including the military, veterans' hospitals, and other government entities.

Generated 11/11/24, 9:22 AM